vimarsana.com
Home
Live Updates
Anteris Technologies fields "excellent" 30-day haemodynamic
Anteris Technologies fields "excellent" 30-day haemodynamic
Anteris Technologies fields "excellent" 30-day haemodynamic results for DurAVR™ THV in US early feasibility study
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has released 30-day data described as "excellent" from its US early feasibility study (EFS) for the DurAVR™...
Related Keywords
Wayne Paterson ,
Chris Meduri ,
Michael Reardon ,
Anteris Technologies Ltd ,
Effective Orifice Area ,
Pressure Gradient ,
Velocity Index ,
Balloon Expandable ,